19th Annual International Ultmann Chicago Lymphoma Symposium

Chicago, IL US
April 29, 2022 to April 30, 2022
The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.
 
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers.
 
This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. This year’s meeting will be a 2-day live meeting to discuss recent updates in the care of patients with solid and hematologic malignancies.  A virtual live stream option will also be available for participants unable to travel.
 
Learn more at the symposium website!                                                   
 

Target Audience

This activity is designed for practicing oncologists, advanced nurse practitioners, physician assistants, residents, fellows, nurses, pharmacists, and other healthcare professionals interested in the treatment and diagnosis of lymphoma.

Learning Objectives

At the conclusion of this educational activity, participants will be able to:

  • Compare and contrast the latest approaches to the treatment of patients with indolent and aggressive forms of non-Hodgkin lymphoma;
  • Evaluate current and emerging approaches to the treatment of patients with Hodgkin lymphoma;
  • Assess the latest clinical trial data of current and emerging CAR T-cells and cellular therapy for patients with hematologic malignancies, including important safety and efficacy data;
  • Discuss patient and disease-related factors that impact the selection and sequencing of therapy for patients with CLL;
  • Develop strategies to utilize the entire multidisciplinary team during the continuum of care of patients with lymphoma.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
Conference Secretariat
CME Coordinator Contact Email: 
Summary
Available credit: 
  • 14.50 ABIM
  • 14.50 AMA PRA Category 1 Credit™
  • 14.50 Nursing Contact Hours
  • 14.50 Participation
Event starts: 
04/29/2022 - 8:00am
Event ends: 
04/30/2022 - 4:20pm
Activity opens: 
04/30/2022
Activity expires: 
08/12/2022
Fairmont Chicago at Millennium Park
200 North Columbus Drive
Chicago, IL 60601
United States
HYBRID CONFERENCE
Learners can attend this event in person or virtually. For questions about the event, contact the Conference Secretariat via e-mail.
WANT TO KNOW MORE?
Learn more about the program by visiting the symposium website!   
 

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via e-mail at iucls@bioascend.com.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

SYMPOSIUM CO-CHAIRS
  Sonali M. Smith, MD
  Elwood V. Jensen Professor of Medicine
  Chief, Section of Hematology/Oncology
  Director, Lymphoma Program
  The University of Chicago
 
  Andrew M. Evens, DO, MSc
  Professor of Medicine, Rutgers Robert Wood Johnson Medical School 
  Associate Director for Clinical Services, Rutger Cancer Institute of New Jersey
  Director, Lymphoma Program, Division of Blood Disorders 
  Medical Director, Oncology Service Line, RWJBarnabas Health
 
  Timothy S. Fenske, MD
  Professor, Division of Hematology and Oncology
  Medical College of Wisconsin
  Milwaukee, Wisconsin
 
 
 



Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit
The University of Chicago Medicine is an approved provider of continuing nursing education by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)

This live activity is designated for a maximum of 14.5 continuing nursing education units.
 
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits from organizations accredited by the ACCME, please consult your professional licensing board.


Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.

REGISTRATION
Preview conference fees below then click the button to register! Early bird rates expire March 29, 2022!


Symposium and Nursing Session

 Access Type   
Early Bird Fee
After Early Bird FeeVirtual 
Physicians$325$375$125
Nurse/OHP$150$175$75
Resident/Fellow$125$150$50
Industry$600$750$200
 
Symposium ONLY
 
Access TypeEarly Bird FeeAfter Early Bird FeeVirtual
Physicians$275$325$50
Nurse/OHP$125$150$25
Resident/Fellow$100$125$25
Industry$450$150$125
 
Industry
 
Access TypeEarly Bird FeeAfter Early Bird FeeVirtual
Physicians$100$150$50
Nurse/OHP$75$100$25
Resident/Fellow$75$100$25
Industry$150$200$125
 
All conference fees will be charged a non-refundable 3% credit card processing fee during registration.
 
CANCELLATION POLICY:  Any cancellations must be made in writing and sent to iucls@bioascend.com A registrant will receive a return of 50% (minus a processing fee) on refunds requested after March 29, 2022.
 
 
 
 
 
CLAIMING CREDIT

After the conference, create an account or log in and enter the access code to unlock the credit claiming process.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.

Please login or create an account to proceed.